#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Keratosis follicular Becker's muscular dystrophy Osteosarcoma Chronic cutaneous lupus erythematosus HER2 gene amplification Infantile spasms Hypergammaglobulinaemia benign monoclonal Adrenogenital syndrome Retinal artery occlusion Infertility female Acute myeloid leukaemia Guillain-Barre syndrome Mucous membrane pemphigoid Glioma Chondrosarcoma metastatic More trials…

    Learn about Rare Diseases

    Primary immunodeficiency syndrome – Treatment Pleomorphic leiomyosarcoma – Basic Information Choroid melanoma – Trials in Disease Tuberous sclerosis complex Fragile X syndrome – Diagnostics Leukoencephalopathy – Diagnostics Myxofibrosarcoma – Life with Disease Glomerulonephritis membranoproliferative – Trials in Disease Atypical haemolytic uraemic syndrome – Diagnostics Pemphigus – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mk-1088 Carfilzomib Edg-5506 Ascorbic Acid Bp Nizatidine Selumetinib Cabergoline Glibenclamide Tertomotide Oxycodone Hydrochloride Hydralazine Hydrochloride Nortriptyline Hydrochloride Foscarnet Sodium Hexahydrate Thiocolchicoside Rupatadine Nemvaleukin Alfa Sulfamethizole Terbinafine Hydrochloride Sildenafil Upacicalcet Sodium Hydrate More therapies…

    Learn about Your Condition

    Lymphangioleiomyomatosis Salivary gland cancer Arginase deficiency Anogenital dysplasia Psoriasis Adrenocortical carcinoma Candida infection Electronic cigarette user Mixed-type liposarcoma Diabetes mellitus Neurodevelopmental disorder Dysmenorrhoea Food allergy Femoral hernia Oedema More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Woluwe-Saint-Lambert

  • Study on the Effectiveness and Safety of Ruxolitinib Cream for Patients with Prurigo Nodularis

    Not recruiting

    3 1
    Investigated Drugs:
    • Ruxolitinib
    Belgium France Germany Italy The Netherlands Poland +1
  • Study on Shortening Antibiotic Treatment for Febrile Neutropenia in Hematology Patients Using Cefepime and Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Febrile neutropenia
    Investigated Drugs:
    • Ceftazidime
    • Meropenem
    • Piperacillin
    Belgium
  • Study Comparing MK-1308A and Pembrolizumab for Patients with Advanced Colorectal Cancer with High Microsatellite Instability or Mismatch Repair Deficiency

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Colorectal cancer stage IV
    • Microsatellite instability cancer
    Investigated Drugs:
    • Quavonlimab
    • Favezelimab
    • Mk-4830
    Belgium Denmark Estonia France Germany Greece +7
  • Study on Long-term Safety of Apremilast in Children Aged 6-17 with Moderate to Severe Plaque Psoriasis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriasis
    Belgium Czechia Italy Spain
  • Study Comparing Patritumab Deruxtecan and Platinum-based Chemotherapy for Patients with Advanced EGFR-mutated Non-small Cell Lung Cancer After EGFR Therapy Failure

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Patritumab Deruxtecan
    Austria Belgium France Germany Italy The Netherlands +4
  • Study of Rocatinlimab in Adults with Prurigo Nodularis Not Adequately Controlled by Topical Treatments

    Not recruiting

    3 1
    Investigated Drugs:
    • Rocatinlimab
    Austria Belgium Finland France Germany Greece +9
Previous Page
1 … 99 100 101 102 103 104
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Pembrolizumab Carboplatin Paclitaxel Cisplatin Cyclophosphamide Fluorouracil Oxaliplatin Doxorubicin Hydrochloride Dexamethasone Vincristine Sulfate Capecitabine Etoposide Bevacizumab Nivolumab Docetaxel Gemcitabine Fulvestrant Rituximab Folinic Acid Letrozole Prednisone Irinotecan Tocilizumab Paclitaxel Albumin-Bound Trastuzumab Methotrexate Mycophenolate Mofetil Durvalumab Upadacitinib Cytarabine Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acute coronary syndrome Acute graft versus host disease in intestine Acute hepatic failure Acute kidney injury Acute lymphocytic leukaemia Acute myeloid leukaemia Adenocarcinoma gastric Adenocarcinoma of colon Adenocarcinoma pancreas Adrenogenital syndrome Alagille syndrome Allogenic stem cell transplantation Alopecia areata Alport's syndrome Anaplastic large cell lymphoma T- and null-cell types Anhedonia Arteriosclerosis Arteriovenous malformation Asthma Athetosis Atrial fibrillation Atypical teratoid/rhabdoid tumour of CNS Autoimmune haemolytic anaemia Autologous haematopoietic stem cell transplant Axial spondyloarthritis B-cell lymphoma B-cell lymphoma recurrent B-cell lymphoma refractory B-cell small lymphocytic lymphoma B-cell small lymphocytic lymphoma recurrent B-cell small lymphocytic lymphoma refractory Bile duct cancer Biliary cancer metastatic Biliary neoplasm Bladder cancer Bladder transitional cell carcinoma Breast cancer Breast cancer female Breast cancer metastatic Breast cancer stage IV Bronchiectasis Bronchopulmonary aspergillosis Bronchopulmonary dysplasia Burkitt's lymphoma Cachexia Cardiac failure Cardiac sarcoidosis Cardiomyopathy Cardiovascular disorder CDKL5 deficiency disorder Central nervous system lymphoma Central nervous system melanoma Cerebral haemorrhage Cerebral palsy Cerebrovascular accident prophylaxis Cervix carcinoma Cervix carcinoma recurrent Cholangiocarcinoma Cholangitis sclerosing Chondrosarcoma Chorea Choreoathetosis Choroid melanoma Chronic cutaneous lupus erythematosus Chronic graft versus host disease Chronic hepatitis B Chronic inflammatory demyelinating polyradiculoneuropathy Chronic kidney disease Chronic lymphocytic leukaemia Chronic obstructive pulmonary disease Chronic rhinosinusitis with nasal polyps Chronic rhinosinusitis without nasal polyps Chronic sinusitis Chronic spontaneous urticaria Clear cell renal cell carcinoma Clostridium difficile infection Coagulation factor X level Coeliac disease Colitis ulcerative Colon cancer Colon cancer metastatic Colorectal adenocarcinoma Colorectal cancer Colorectal cancer metastatic Colorectal cancer stage III Colorectal cancer stage IV Congenital absence of bile ducts Congenital cystic kidney disease Congenital pseudarthrosis Coronary artery disease Cough Critical illness Crohn's disease Cutaneous lupus erythematosus Cystic fibrosis Dementia Alzheimer's type Demyelination Dermatitis atopic Desmoid tumour Diabetic gastroparesis Diffuse large B-cell lymphoma Diffuse large B-cell lymphoma recurrent Diffuse large B-cell lymphoma refractory Ductal adenocarcinoma of pancreas Dyskinesia Dyslipidaemia Dystonia Endocrine ophthalmopathy Endometrial adenocarcinoma Endometrial cancer Endometrial cancer metastatic Endometrial cancer recurrent Endometriosis Ependymoma Ewing's sarcoma Ewing's sarcoma metastatic Ewing's sarcoma recurrent Extra-osseous Ewing's sarcoma Extra-osseous Ewing's sarcoma metastatic Extra-osseous Ewing's sarcoma recurrent Factor IX deficiency Factor VIII deficiency Fallopian tube cancer Fallopian tube cancer stage III Fallopian tube cancer stage IV Febrile neutropenia Focal segmental glomerulosclerosis Follicular lymphoma Fungal infection Gallbladder cancer Gastric cancer Gastric cancer recurrent Gastroenteropancreatic neuroendocrine tumour disease Gastrointestinal carcinoma Gastrointestinal melanoma Gastrooesophageal cancer Generalised tonic-clonic seizure Giant cell tumour of tendon sheath Glioblastoma Glioma Glomerulonephritis membranous Graft versus host disease Haemolytic uraemic syndrome Haemophilia Haemophilia A with anti factor VIII Haemophilia A without inhibitors Haemophilia B without inhibitors Haemorrhagic stroke Head and neck cancer Henoch-Schonlein purpura nephritis Hepatic cancer Hepatic cirrhosis Hepatobiliary cancer Hepatoblastoma Hepatocellular carcinoma HER2 gene amplification HER2 positive breast cancer HER2 positive gastric cancer Hereditary angioedema Herpes simplex Hidradenitis HIV infection Hodgkin's disease Homocystinuria Hormone receptor positive breast cancer Hormone receptor positive HER2 negative breast cancer Hormone-dependent prostate cancer Hormone-refractory prostate cancer Human epidermal growth factor receptor negative Hyperoxaluria Hypertension Hypertrophic cardiomyopathy Idiopathic pulmonary fibrosis IgA nephropathy Impaired gastric emptying Inborn error of metabolism Indolent systemic mastocytosis Infantile apnoea Infection in an immunocompromised host Infertility female Infertility male Interstitial lung disease Ischaemic stroke Juvenile idiopathic arthritis Juvenile psoriatic arthritis Juvenile spondyloarthritis K-ras gene mutation Kidney transplant rejection Laryngeal squamous cell carcinoma Left ventricular dysfunction Leiomyosarcoma metastatic Liver transplant rejection Lung adenocarcinoma Lupus nephritis Lymphangioma Lymphatic malformation Lymphocytic leukaemia Major depression Malignant glioma Malignant mast cell neoplasm Malignant melanoma Malignant melanoma of eyelid Malignant melanoma stage III Malignant melanoma stage IV Malignant neoplasm of choroid Malignant peritoneal neoplasm Marginal zone lymphoma Marginal zone lymphoma refractory Medulloblastoma Melanoma recurrent Menopausal symptoms Metabolic dysfunction-associated liver disease Metabolic dysfunction-associated steatohepatitis Metastases to peritoneum Metastatic gastric cancer Metastatic malignant melanoma Microsatellite instability cancer Monkeypox Multifocal motor neuropathy Multiple sclerosis Multiple sclerosis relapse Myasthenia gravis Myelodysplastic syndrome Myelodysplastic syndrome with excess blasts Myelofibrosis Narcolepsy Neoplasm Neoplasm malignant Nephroblastoma Nephrogenic anaemia Nephrotic syndrome Neuroblastoma Neurodermatitis Neuroendocrine carcinoma Neuroendocrine tumour Neuroendocrine tumour of the lung Non-alcoholic steatohepatitis Non-Hodgkin's lymphoma Non-small cell lung cancer Non-small cell lung cancer metastatic Non-small cell lung cancer stage III Non-small cell lung cancer stage IIIA Non-small cell lung cancer stage IIIB Non-small cell lung cancer stage IV Noonan syndrome Obesity Oesophageal adenocarcinoma Oesophageal adenocarcinoma stage II Oesophageal adenocarcinoma stage III Oesophageal cancer metastatic Oesophageal carcinoma Oesophageal squamous cell carcinoma Oesophageal squamous cell carcinoma stage II Oesophageal squamous cell carcinoma stage III Oral herpes Oropharyngeal squamous cell carcinoma Osteosarcoma Ovarian cancer Ovarian cancer stage III Ovarian cancer stage IV Ovarian endometrioid carcinoma Ovarian epithelial cancer Pancreatic carcinoma Pancreatic carcinoma metastatic Pancreatic neuroendocrine tumour Paranasal sinus inflammation Paroxysmal nocturnal haemoglobinuria Partial seizures Periodontitis Peripheral T-cell lymphoma unspecified Peritoneal cancer index Peritoneal carcinoma metastatic Peritoneal neoplasm PIK3CA related overgrowth spectrum PIK3CA-activated mutation Plasma cell myeloma Plasma cell myeloma refractory Pneumonia Pre-eclampsia Primary biliary cholangitis Primary hyperoxaluria Primary myelofibrosis Primary progressive multiple sclerosis Progressive familial intrahepatic cholestasis Progressive relapsing multiple sclerosis Prostate cancer Prostate cancer metastatic Proteinuria Psoriasis Psoriatic arthropathy Pulmonary embolism Pulmonary fibrosis Pustular psoriasis Pyoderma gangrenosum Rabies Rectal cancer stage II Rectal cancer stage III Relapsing multiple sclerosis Renal cancer Renal cell carcinoma Renal transplant Respiratory syncytial virus infection Rett syndrome Rhabdomyosarcoma Rheumatoid arthritis Secondary progressive multiple sclerosis Sepsis Short stature Sinusitis noninfective Sleep disorder Small cell lung cancer Small cell lung cancer extensive stage Small cell lung cancer limited stage Small for dates baby Small intestine adenocarcinoma Squamous cell carcinoma Squamous cell carcinoma of head and neck Squamous cell carcinoma of lung Squamous cell carcinoma of skin Squamous cell carcinoma of the hypopharynx Still's disease Subacute cutaneous lupus erythematosus Systemic candida Systemic lupus erythematosus Thrombosis prophylaxis Thrombotic microangiopathy Transient ischaemic attack Transitional cell cancer of the renal pelvis and ureter Transitional cell carcinoma Transitional cell carcinoma metastatic Transitional cell carcinoma urethra Triple negative breast cancer Trisomy 21 Turner's syndrome Type IIa hyperlipidaemia Urea cycle disorder Uveal melanoma Varicella Vascular malformation Vitiligo Waldenstrom's macroglobulinaemia

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!